finanzen.net

EVOTEC Aktie WKN: 566480     / ISIN: DE0005664809    

25,83EUR
-0,21EUR
-0,81%
20:15:03
KAUFEN
VERKAUFEN
mehr Daten anzeigen

EVOTEC Aktien News

19.02.20
Sanofi, J&J Join Forces With BARDA for Coronavirus Vaccine (Zacks)
19.02.20
AstraZeneca PLC : Director/PDMR Shareholding (Investegate)
19.02.20
FDA grants priority review to Roche’s Tecentriq monotherapy as first-line treatment of certain people with advanced non-small cell lung cancer (Roche Holding AG)
19.02.20
F. Hoffmann-La Roche Ltd : FDA grants priority review to Roche’s Tecentriq monotherapy as first-line treatment of certain people with advanced non-small cell lung cancer (Investegate)
18.02.20
Pfizer Gains European Approval for Amyloidosis Drug Vyndaqel (MotleyFool)
18.02.20
Sanofi Gets Backing From U.S. Government to Develop a COVID-19 Vaccine (MotleyFool)
18.02.20
UPDATE 2-Sanofi teams up with U.S. agency against coronavirus (Reuters)
18.02.20
UPDATE 1-Sanofi teams up with U.S. agency against coronavirus (Reuters)
18.02.20
Sanofi to work on coronavirus vaccine (Market Watch)
18.02.20
Sanofi partners with U.S. agency to develop coronavirus vaccine (Reuters)
18.02.20
Sanofi : Sanofi joins forces with U.S. Department of Health and Human Services to advance a novel coronavirus vaccine (Investegate)
17.02.20
Press Release: Novartis receives EC Approval for -2- (Dow Jones)
17.02.20
Press Release: Novartis receives EC Approval for Beovu(R), a next-generation anti-VEGF treatment for wet AMD, a leading cause of blindness worldwide (Dow Jones)
17.02.20
NOVARTIS AG CHF0.50(REGD) : Novartis receives EC Approval for Beovu®, a next-generation anti-VEGF treatment for wet AMD, a leading cause of blindness worldwide (Investegate)
15.02.20
AstraZeneca Announces Q4 Financial Results, Coronavirus Fears Weigh on Guidance (MotleyFool)
15.02.20
Pfizer-backed biopharma company Imara files for IPO (Market Watch)
14.02.20
AstraZeneca PLC (AZN) Q4 2019 Earnings Call Transcript (MotleyFool)
14.02.20
AstraZeneca braces for coronavirus hit, but no impact so far (Reuters)
14.02.20
AstraZeneca braces for coronavirus hit, but no impact so far (CNBC)
14.02.20
AstraZeneca Stock Dives As Coronavirus Expected To Batter 2020 Results (Investors Business Daily)
14.02.20
AstraZeneca warns on ‘unfavourable impact’ from coronavirus outbreak (Belfast Telegraph)
14.02.20
AstraZeneca 2020 forecasts hit by coronavirus, shares dive (Reuters)
14.02.20
AstraZeneca warns of coronavirus hit to growth (Financial Times)
14.02.20
Dow Jones Newswires: AstraZeneca profit misses forecasts and warns outlook hinges on COVID-19 (MarketWatch)
14.02.20
AstraZeneca PLC : AZN: Full-year and Q4 2019 results (Investegate)
14.02.20
China National Medical Products Administration grants approval of Roche’s Tecentriq in combination with chemotherapy as first-line treatment of people with extensive-stage small cell lung cancer (Roche Holding AG)
13.02.20
Is Sanofi (SNY) Stock Undervalued Right Now? (Zacks)
11.02.20
4 Senior Executives Are Leaving Sanofi Following New CEO's Strategic Overhaul (MotleyFool)
11.02.20
Potential Lung Cancer Drug from Incyte and Novartis to Get a Priority Review from FDA (MotleyFool)
11.02.20
The Zacks Analyst Blog Highlights: Microsoft, JP Morgan Chase and Pfizer (Zacks)
11.02.20
Better Buy: Pfizer vs. AbbVie (MotleyFool)
11.02.20
What's in Store for AstraZeneca (AZN) This Earnings Season? (Zacks)
11.02.20
Press Release: Novartis announces MET inhibitor -2- (Dow Jones)
11.02.20
Press Release: Novartis announces MET inhibitor capmatinib (INC280), the first potential treatment for METex14 mutated advanced non-small cell lung cancer, g... (Dow Jones)
11.02.20
NOVARTIS AG CHF0.50(REGD) : Novartis announces MET inhibitor capmatinib (INC280), the first potential treatment for METex14 mutated advanced non-small cell lung cancer, granted priority FDA review (Investegate)
10.02.20
Roche Reports Disappointing Data on Alzheimer's Disease Drug (Zacks)
10.02.20
Roche and Eli Lilly drugs fail ‘inherited’ Alzheimer’s trial (Financial Times)
10.02.20
Roche, Lilly drugs fail to halt gene-driven Alzheimer's disease (Reuters)
10.02.20
The Zacks Analyst Blog Highlights: Alphabet, Roche, Amgen, General Electric and Sony (Zacks)
10.02.20
UPDATE 2-Roche, Lilly drugs fail to halt gene-driven Alzheimer's disease (Reuters)
Seite: 123456789...25

EVOTEC News

EVOTEC News: auf dieser Seite finden Sie alle EVOTEC News und Nachrichten zur EVOTEC Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch EVOTEC News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um EVOTEC News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
NEL ASAA0B733
Ballard Power Inc.A0RENB
TeslaA1CX3T
PowerCell Sweden ABA14TK6
Wirecard AG747206
Plug Power Inc.A1JA81
Deutsche Bank AG514000
Deutsche Telekom AG555750
Varta AGA0TGJ5
Daimler AG710000
ITM Power plcA0B57L
Microsoft Corp.870747
SteinhoffA14XB9
Apple Inc.865985
Amazon906866